Connective Portfolio Management, LLC Ventyx Biosciences, Inc. Transaction History
Connective Portfolio Management, LLC
- $62.5 Million
- Q4 2024
Shares
1 transactions
Others Institutions Holding VTYX
# of Institutions
132Shares Held
55.2MCall Options Held
81.4KPut Options Held
148K-
Black Rock Inc. New York, NY4.77MShares$5.77 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.48MShares$5.42 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.27MShares$5.17 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY4.05MShares$4.9 Million3.31% of portfolio
-
Ubs Group Ag3.78MShares$4.58 Million0.0% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $68.4M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...